SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-059523
Filing Date
2020-11-19
Accepted
2020-11-19 18:57:11
Documents
1
Period of Report
2020-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6607
  Complete submission text file 0001209191-20-059523.txt   7971
Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Moriarty John B (Reporting) CIK: 0001564621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 201330026

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations